Our Collaborating Partners
Bridging Gaps in Research
Our Collaborating Partners
Dr. Frankovich is a Clinical Professor in the Department of Pediatrics, Division of Allergy, Immunology Rheumatology (AIR) at Stanford University/Lucile Packard Children’s Hospital (LPCH). Frankovich’s clinical expertise is in systemic inflammatory and autoimmune diseases that co-occur with psychiatric symptoms. She completed her training in pediatrics, pediatric rheumatology, and clinical epidemiology at Stanford. Dr. Frankovich directs the Stanford PANS Program (2012- present) and along with her collaborators have created a longitudinal clinical database and large biorepository of patient and control biospecimens.
Galatea Bio leverages world class ancestry algorithms to better understand underserved Latin American populations while maintaining a strong commitment to ethical research. Galatea Bio has identified a gap in global biobanking efforts: they have focused primarily on nothern European communities. Galatea Bio aims to expand the diversity of the dataset in order to dramatically accelerate the discovery rate in the field of genomics, and help narrow the gap in health outcomes for underrepresented minorities.
PANDAS Network is a non-profit support network for individuals suffering from Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) and Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). PANDAS Network aims to improve the diagnosis and treatment of children with PANDAS. Armed with an impressive network of doctors, researchers and scientists, PANDAS Network builds public awareness, provides much-needed support to families and gathers data and resources to better inform parents and the medical community about PANDAS/PANS.
The Biobank of the Americas is a public-private consortium bringing together diverse organizations under one common goal: build the largest genomic database focused on underrepresented populations.
Drumroll.ai is an analytics platform designed to give everyone the easiest and fastest way to undersatnd their data – regardless of technical abilities or resources. They offer several AI and Machine Learning products designed to assist in data preparation, utilizing dozens of algorithms to scan, interpret, encode, and arrange data. Features include the ability to personalize and adjust data settings before it is computed, use of fully automated queries (no coding required), and ability to generate meaningful insights (correlations, comparisons, clusters, and more) in mere seconds.
Dr. Madeleine Cunningham, PhD is a George Lynn Cross Research Professor of Autoimmunity and Infection at the University of Oklahoma College of Medicine. Dr. Cunningham’s laboratory has been highly focused on the investigation of molecular mimicry, autoimmunity and infection in inflammatory heart disease for the past 20 years.
TrialKit by Crucial Data Solutions takes advantage of the mobile revolution to allow participants and researchers to input and monitor study data from anywhere, anytime. TrialKit is the industry’s only solution that can be used via a web browser or the native mobile app. Fully enabling virtual trials across all clinical trial phases as well as for real world studies.
WCG has 50 years experience offering best-in-class clinical services along with 3,300 institutional and 4,000 employees worldwide. Brain Inflammation Collaborative partners with a business unit of WCG, WCG Avoca who is a leader in providing GCP quality and compliance solutions and strives for future-forward leadership in regulatory compliance, quality management, and clinical operations across an evolving clinical trials landscape.
The Autoimmune Registry is a hub for research, statistics, and patient data on all autoimmune disease. Its goal is to collect data on autoimmune incidence, demographic background, and survival rates in the United States to improve understanding of autoimmune diseases, the populations they affect, their risks for comorbid diseases, and their natural progression over time.
Lumos Labs, creator of Lumosity is a science team committed to translating cognitive science into accessible brain training. Their scientists research well-known methods of training cognitive abilities like Memory and Attention, design a game that effectively challenges a particular cognitive ability, and create the game, keeping brain training both fun and challenging.
Moleculera Labs is dedicated to the discovery and delivery of advanced diagnostic testing services for children and adults suffering from traeatable auotimmune neuropsychiatric disorders. Moleculera Labs is the sole provider of a testing panel which assists physicians in their diagnosis of autoimmune neuropsychiatric disorders, such as PANS and PANDAS. The Cunningham Panel™ is the first and only test of its kind in the world, and is the result of more than a decade of research and development.